Teva, Barr Join for At-Risk Launch of Generic Allegra

Drug Industry Daily
KEYWORDS Deals / Patents
A A

Rivals Barr Pharmaceuticals and Teva Pharmaceutical have partnered to market a generic version of sanofi-aventis’ blockbuster allergy drug Allegra, the companies said Sept. 6. Barr received final FDA approval to market its version of the drug last week.

To View This Article:

Login

Subscribe To Drug Industry Daily